Silver Book Fact

Growth hormone treatment in patients with fibromyalgia is effective in reducing pain with sustained action over time.

Cuatrecasas, Guileem, C Alegre, J Fernandez-Sola, MJ Gonzalez, F Garcia-Fructuoso, V Poca-Dias, A Nadal, Gabriel Cuatrecasas, F Navarro, A Mera, M Lage, R Peino, F Casanueva, C Linan, G Sesmilo, MJ Coves, JP Izquierdo, I Alvarez, E Granadas, adn M Puig-Domingo. Growth Hormone Treatment for Sustained Pain Reduction and Improvement in Quality of Life in Severe Fibromyalgia. Pain. 2012; 153(7): 1382-9. http://www.ncbi.nlm.nih.gov/pubmed/22465047

Reference

Title
Growth Hormone Treatment for Sustained Pain Reduction and Improvement in Quality of Life in Severe Fibromyalgia
Publication
Pain
Publication Date
2012
Authors
Cuatrecasas, Guileem, C Alegre, J Fernandez-Sola, MJ Gonzalez, F Garcia-Fructuoso, V Poca-Dias, A Nadal, Gabriel Cuatrecasas, F Navarro, A Mera, M Lage, R Peino, F Casanueva, C Linan, G Sesmilo, MJ Coves, JP Izquierdo, I Alvarez, E Granadas, adn M Puig-Domingo
Volume & Issue
Volume 153, Issue 7
Pages
1382-9
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • People with persistent pain who used complementary and alternative medicine (CAM) had lower average health care expenditures than nonusers ($3,797 versus $4,153).  
  • Pregalbin, an antiepileptic drug, produced around a 32% pain reduction (a significant reduction) at week 16 versus around 20% for placebo, in patients with neuropathic pain due to spinal cord…  
  • Topical clonidine gel significantly reduces foot pain in patients with painful diabetic neuropathy.  
  • The combination of information for neuroimaging and circulatory biomarkers could improve both the sensitivity and specificity of pain diagnosis and thereby improve treatment.  
  • A meta-analysis of pscychological interventions for chronic low back pain found small but statistically significant effects for all interventions for as long as 5 years.